Improved Survival Through Early Versus Late Impella Support for Myocardial Infarction-Related Shock?: Mind Your Step!

Christiaan L Meuwese; Claartje L A Pladet; Adriaan O Kraaijeveld; Dirk W Donker

doi:10.1097/CCM.0000000000005256

Improved Survival Through Early Versus Late Impella Support for Myocardial Infarction-Related Shock? Mind Your Step!

Christiaan L Meuwese
, Claartje L A Pladet
, Adriaan O Kraaijeveld
, Dirk W Donker

Research output: Contribution to journal › Letter › Academic › peer-review

1 Downloads (Pure)

Original language	English
Pages (from-to)	e1276-e1277
Journal	Critical care medicine
Volume	49
Issue number	12
DOIs	https://doi.org/10.1097/CCM.0000000000005256
Publication status	Published - 1 Dec 2021

Access to Document

10.1097/CCM.0000000000005256

Improved_Survival_Through_Early_Versus_Late.47Final published version, 515 KBLicence: Taverne

Cite this

@article{2b75c8eb937649848979ffaa675c35f4,

title = "Improved Survival Through Early Versus Late Impella Support for Myocardial Infarction-Related Shock?: Mind Your Step!",

author = "Meuwese, \{Christiaan L\} and Pladet, \{Claartje L A\} and Kraaijeveld, \{Adriaan O\} and Donker, \{Dirk W\}",

note = "Funding Information: Dr. Kraaijeveld{\textquoteright}s institution received funding from Xenios and Abiomed; he received funding from Abiomed. Dr. Donker received funding from Getinge Maquet and Fresenius Xenios Nova Lung. The remaining authors have disclosed that they do not have any potential conflicts of interest. ",

year = "2021",

month = dec,

day = "1",

doi = "10.1097/CCM.0000000000005256",

language = "English",

volume = "49",

pages = "e1276--e1277",

journal = "Critical care medicine",

issn = "0090-3493",

publisher = "Lippincott Williams \& Wilkins",

number = "12",

}

TY - JOUR

T1 - Improved Survival Through Early Versus Late Impella Support for Myocardial Infarction-Related Shock?

T2 - Mind Your Step!

AU - Meuwese, Christiaan L

AU - Pladet, Claartje L A

AU - Kraaijeveld, Adriaan O

AU - Donker, Dirk W

N1 - Funding Information: Dr. Kraaijeveld’s institution received funding from Xenios and Abiomed; he received funding from Abiomed. Dr. Donker received funding from Getinge Maquet and Fresenius Xenios Nova Lung. The remaining authors have disclosed that they do not have any potential conflicts of interest.

PY - 2021/12/1

Y1 - 2021/12/1

UR - https://www.scopus.com/pages/publications/85121994129

U2 - 10.1097/CCM.0000000000005256

DO - 10.1097/CCM.0000000000005256

M3 - Letter

C2 - 34793400

SN - 0090-3493

VL - 49

SP - e1276-e1277

JO - Critical care medicine

JF - Critical care medicine

IS - 12

ER -

Improved Survival Through Early Versus Late Impella Support for Myocardial Infarction-Related Shock? Mind Your Step!

Access to Document

Other files and links

Cite this